Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04473430 · ClinicalTrials.gov registry record · NA
Study to Determine the Efficacy of Real-time CGM in Preventing Hypoglycemia Among Insulin-treated Patients With DM2 on Hemodialysis, Compared to Standard of Care (POC BG)
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT04473430 is a NA study that has completed, run by Emory University. The registered enrollment target is 53 participants.
The verdict
NCT04473430, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
The study is conducted to assess the efficacy of real-time CGM data in preventing hypoglycemia in patients with type 2 diabetes and end-stage kidney disease (ESKD), treated with insulin therapy and receiving hemodialysis.
Interventions
- DEVICE Dexcom Real-time G6 Continuous Glucose Monitoring System (CGM)
- DEVICE POC Glucose Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2020-11-05 |
| Est. Completion | 2023-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04473430
The ClinicalTrials.gov registry entry for NCT04473430 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexcom Real-time G6 Continuous Glucose Monitoring System (CGM) is the first listed.
NCT04473430 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04473430 about?
NCT04473430 is a clinical study titled "Study to Determine the Efficacy of Real-time CGM in Preventing Hypoglycemia Among Insulin-treated Patients With DM2 on Hemodialysis, Compared to Standard of Care (POC BG)". The study is conducted to assess the efficacy of real-time CGM data in preventing hypoglycemia in patients with type 2 diabetes and end-stage kidney disease (ESKD), treated with insulin therapy and receiving hemodialysis.
What is the current status of trial NCT04473430?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2020-11-05. Estimated completion is 2023-10-31.
What interventions are being tested in trial NCT04473430?
The interventions under investigation include: Dexcom Real-time G6 Continuous Glucose Monitoring System (CGM) (DEVICE), POC Glucose Testing (DEVICE).
Who is sponsoring clinical trial NCT04473430?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.